Cover Image
市场调查报告书

欧洲的整形外科用生医材料市场

Europe Markets for Orthopedic Biomaterials 2011-2021

出版商 iData Research Inc. 商品编码 288794
出版日期 内容信息 英文 350 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
欧洲的整形外科用生医材料市场 Europe Markets for Orthopedic Biomaterials 2011-2021
出版日期: 2015年06月01日 内容信息: 英文 350 Pages
简介

欧洲的整形外科用生医材料市场预计至2019年成为3亿7,670万欧元。尤其玻尿酸关节内补充是最大的市场区隔。

本报告提供同市场概要各市场区隔、各国概要、预测、策略性市场机会等汇整数据,为您概述为以下内容。

第1章 摘要整理

第2章 调查方法

第3章 欧洲的整形外科用生医材料市场

  • 简介
    • 产品
  • 目前汇率
  • 市场概要
  • 趋势分析
  • 促进因素与阻碍因素
  • 竞争分析
  • 合并、收购

第4章 国家概况

  • 简介
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 荷比卢三国
  • 北欧各国
  • 奥地利
  • 瑞士
  • 葡萄牙

第5章 人工骨骼替代物市场

  • 简介
  • 市场概要
    • 各适应症
    • 各市场区隔
  • 市场分析与预测
    • 市场整体
    • 异体移植片市场
    • 合成市场
    • 脱钙骨基质市场
  • 促进因素与阻碍因素
  • 竞争分析

第6章 玻尿酸关节内补充市场

  • 简介
  • 市场概要
  • 市场分析与预测
    • 市场整体
    • 单次注射市场
    • 3次输液市场
    • 5次输液市场
  • 促进因素与阻碍因素
  • 竞争分析

第7章 骨骼成型蛋白生长因子治疗市场

  • 简介
  • 市场概要
  • 市场分析与预测
  • 促进因素与阻碍因素
  • 竞争分析

第8章 自体软骨细胞移植市场

  • 简介
    • 自体软骨细胞移植治疗的未来性
  • 市场分析与预测
  • 促进因素与阻碍因素
  • 竞争分析

简称

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: iDATA_EUOB15_RPT

The European market for orthopedic materials is segmented into bone graft substitutes (BGS), which includes allograft, synthetic and demineralized bone matrices (DBM); bone morphogenetic protein (BMP) growth factors; hyaluronic acid (HA) viscosupplementation; and autologous chondrocyte implantation (ACI).

The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation injections, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantations (ACI). The HA market experienced significant contractions in 2012 and 2013 due to the extreme price competition resulting from an increase in competition, especially in Germany.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 EUROPEAN MARKETS FOR ORTHOPEDIC BIOMATERIALS
  • 1.2 BONE GRAFT SUBSTITUTE MARKET
  • 1.3 ALLOGRAFT BONE GRAFT SUBSTITUTE MARKET
  • 1.4 SYNTHETIC BONE GRAFT SUBSTITUTE MARKET
  • 1.5 DEMINERALIZED BONE MATRIX BONE GRAFT SUBSTITUTE MARKET
  • 1.6 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
  • 1.7 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET
  • 1.8 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
  • 1.9 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET

  • 3.1 INTRODUCTION
    • 3.1.1 Products
      • 3.1.1.1 Growth Factors
      • 3.1.1.2 Bone Graft Substitutes
      • 3.1.1.3 Hyaluronic Acid Viscosupplementation
      • 3.1.1.4 Autologous Chondrocyte Implantation
  • 3.2 CURRENCY EXCHANGE RATE
  • 3.3 MARKET OVERVIEW
  • 3.4 TREND ANALYSIS
  • 3.5 DRIVERS AND LIMITERS
    • 3.5.1 Market Drivers
    • 3.5.2 Market Limiters
  • 3.6 COMPETITIVE ANALYSIS
  • 3.7 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

  • 4.1 INTRODUCTION
    • 4.1.1 Population
    • 4.1.2 GDP per Capita
    • 4.1.3 Price Index
  • 4.2 GERMANY
  • 4.3 FRANCE
  • 4.4 UNITED KINGDOM
  • 4.5 ITALY
  • 4.6 SPAIN
  • 4.7 BENELUX
  • 4.8 SCANDINAVIA
  • 4.9 AUSTRIA
  • 4.10 SWITZERLAND
  • 4.11 PORTUGAL

BONE GRAFT SUBSTITUTE MARKET

  • 5.1 INTRODUCTION
    • 5.1.1 Volumes Represented per Procedure
  • 5.2 MARKET OVERVIEW
    • 5.2.1 Bone Graft Substitute Market by Indication
    • 5.2.2 Bone Graft Substitute Market by Segment
  • 5.3 MARKET ANALYSIS AND FORECAST
    • 5.3.1 Total Bone Graft Substitute Market
    • 5.3.2 Total Allograft Market
      • 5.3.2.1 Total Allograft Spine Market
        • 5.3.2.1.1 Allograft Cervical Spine Market
        • 5.3.2.1.2 Allograft Thoracolumbar Spine Market
      • 5.3.2.2 Allograft Trauma and Reconstruction Market
      • 5.3.2.3 Allograft Craniomaxillofacial Market
    • 5.3.3 Total Synthetic Market
      • 5.3.3.1 Total Synthetic Spine Market
        • 5.3.3.1.1 Synthetic Cervical Spine Market
        • 5.3.3.1.2 Synthetic Thoracolumbar Spine Market
      • 5.3.3.2 Synthetic Trauma and Reconstruction Market
      • 5.3.3.3 Synthetic Craniomaxillofacial Market
    • 5.3.4 Total Demineralized Bone Matrix Market
      • 5.3.4.1 Total Demineralized Bone Matrix Spine Market
        • 5.3.4.1.1 Demineralized Bone Matrix Cervical Spine Market
        • 5.3.4.1.2 Demineralized Bone Matrix Thoracolumbar Spine Market
      • 5.3.4.2 Demineralized Bone Matrix Trauma and Reconstruction Market
      • 5.3.4.3 Demineralized Bone Matrix Craniomaxillofacial Market
  • 5.4 DRIVERS AND LIMITERS
    • 5.4.1 Market Drivers
    • 5.4.2 Market Limiters
  • 5.5 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 6.1 INTRODUCTION
  • 6.2 MARKET OVERVIEW
  • 6.3 MARKET ANALYSIS AND FORECAST
    • 6.3.1 Total Hyaluronic Acid Viscosupplementation Market
    • 6.3.2 Single-Injection Market
    • 6.3.3 Three-Injection Market
    • 6.3.4 Five-Injection Market
  • 6.4 DRIVERS AND LIMITERS
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 COMPETITIVE ANALYSIS

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • 7.1 INTRODUCTION
  • 7.2 MARKET ANALYSIS AND FORECAST
  • 7.3 MARKET DRIVERS AND LIMITERS
    • 7.3.1 Market Drivers
    • 7.3.2 Market Limiters
  • 7.4 COMPETITIVE ANALYSIS

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

  • 8.1 INTRODUCTION
    • 8.1.1 Future of ACI Treatments
  • 8.2 MARKET ANALYSIS AND FORECAST
  • 8.3 DRIVERS AND LIMITERS
    • 8.3.1 Market Drivers
    • 8.3.2 Market Limiters
  • 8.4 COMPETITIVE ANALYSIS

ABBREVIATIONS

Back to Top